Document Details
Form
Filing Date
Mar 15, 2013
Document Date
Mar 15, 2013
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Travere Therapeutics, Inc.
Issuer
TRAVERE THERAPEUTICS, INC.